COMMUNIQUÉS West-GlobeNewswire

The Drug Committee of Ministry of Health, Labour and Welfare in Japan has accepted a 2-year extension of market exclusivity of Lexapro®
27/04/2018
A two-year extension of the reexamination period by the Japanese Ministry of Health, Labour and Welfare (MHLW) has been discussed and accepted in the First Committee on Drug of MHLW The acceptance is based on the fact [...]
Announcment by Board of JSC “Grindeks”
27/04/2018
Dear shareholders, We kindly inform you that preparing the audited separate and consolidated financial statement of JSC “Grindeks” of 2017 requires more time than initially planned; therefore the audited separate and [...]
Solon Eiendom ASA : Notice of annual general Meeting 23 May 2018
27/04/2018
Oslo, 27 April 2018: Solon Eiendom ASA (OSE: SOLON), calls for the annual general meeting to be held at the company's offices in Olav Vs gate 5, 0161, Oslo, Norway on 23 May 2018 at 10.00 (CET). The notice convening the [...]
Marche de sensibilisation à l’autisme
27/04/2018
MONTRÉAL, 27 avr. 2018 (GLOBE NEWSWIRE) -- Samedi le 28 avril 2018, prendra place la marche pour l’autisme qui clôture le mois de sensibilisation à l’autisme au Québec. Parents, enfants, personnes présentant un trouble [...]
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
27/04/2018
WALTHAM, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that company management will participate in the following investor conferences: Deutsche Bank Annual Health [...]
Spring Bank Pharmaceuticals Provides Corporate Update and Reports First Quarter Financial and Operational Results
27/04/2018
Presented inarigivir 25 mg and 50mg cohorts from Phase 2 ACHIEVE trial in chronic hepatitis B patients at two scientific conferences Continues to advance SB 11285, a next-generation STING agonist, towards clinical trial [...]
Acasti Pharma Appoints Donald Olds to its Board of Directors and Audit Committee
27/04/2018
LAVAL, Québec, April 27, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST ) (TSX-V: ACST ), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug [...]
Zogenix Announces Initial Quality of Life and Cognitive Function Data From Phase 3 Trial of ZX008 in Dravet Syndrome
27/04/2018
ZX008 Patients Experienced Significant Improvements on Select Measures of Quality of Life and Executive Function Compared to Those on Placebo Data Presented During Emerging Therapies Plenary Session at 2018 American [...]
Emblem Announces 2017 Financial Results
27/04/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, April 27, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. ( “Emblem” or the “ Company ”) (TSX-V: EMC ) (EMC.WT), today [...]
INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome
27/04/2018
Study will evaluate safety and efficacy of company’s CBD product candidate in rare genetic disease characterized by insatiable appetite in children PHOENIX, April 27, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. ( [...]
Trevena and Pharmbio Korea Announce License and Commercialization Agreement for Oliceridine in South Korea
27/04/2018
– Pharmbio Korea granted a license to develop, manufacture, and commercialize oliceridine in South Korea – – Trevena to receive upfront and milestone payments and royalties – CHESTERBROOK, Pa. and SEOUL, South Korea, [...]
Establishment Labs Announces Motiva® Implants IDE Clinical Trial Underway with First Patient Enrolled and Surgery Completed
27/04/2018
NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies, today announced the enrollment and successful [...]
Nuvus (NUVG) Signs Letter of Intent With Kunjani Group - Nuvus Brings Its Bio-Agriculture & Blockchain Technology Solutions to Africa
27/04/2018
Kunjani Group Will Hold the Exclusive License for Nuvus Technologies in Sub-Sahara Africa Saint Petersburg, FL, April 27, 2018 (GLOBE NEWSWIRE) -- JOHANNESBURG, SOUTH AFRICA — Nuvus Corp., a pioneer in bio-agricultural [...]
Myriad Genetics to Present at Two Upcoming Healthcare Conferences
27/04/2018
SALT LAKE CITY, April 27, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]
New Study Finds that 24 Percent of Women Seen in the Obstetrics-Gynecology Setting Met NCCN Guidelines for Hereditary Cancer Genetic Testing
27/04/2018
Results from 3,800 Patient Study Will Be Presented at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting SALT LAKE CITY, April 27, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ [...]
Asterias Biotherapeutics to Present AST-OPC1 Program Update at the Upcoming American Society for Neural Therapy and Repair Conference
27/04/2018
FREMONT, Calif., April 27, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with [...]
miRagen Therapeutics Announces New Data Showing Administration of MRG-110 Improved Tissue Perfusion and Wound Healing in Late Stage Preclinical Studies
27/04/2018
MRG-110 appeared to increase vascularization and reparative tissue formation in treated wounds; miRagen believes results support evaluation in human clinical trials MRG-110 treatment appeared to lead to more wounds [...]
Agios Announces Revised Starting Time of 8:00am ET for Investor Day and First Quarter 2018 Financial Results Webcast on Friday, May 4, 2018
27/04/2018
CAMBRIDGE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]
Advantagene Announces Clinical Trial Collaboration
27/04/2018
Clinical Study to Combine GMCI™ with Opdivo® (nivolumab) in the Treatment of Malignant Glioma AUBURNDALE, Mass., April 27, 2018 (GLOBE NEWSWIRE) -- Advantagene, Inc. today announced that the company entered into a [...]

Pages